Table 3.

Treatment for AIH in the Japanese guideline 2013

Treatment
1. Diagnostic confirmation, in principle, should be followed by corticosteroid treatment
2. Prednisolone should be administered at an initial daily dose of 0.6 mg/kg or more, and tapered according to improvements in serum aminotransferase and immunoglobulin G levels. The maintenance dose should be determined after achieving normalized aminotransferase levels
3. Ursodeoxycholic acid (600 mg/day) may be administered concomitantly during the tapering of the prednisolone dose, or alone in mild cases
4. Azathioprine (50 – 100 mg/day) should be administered to patients experiencing repeated relapses or those unable to tolerate the side effects of prednisolone

Adapted from the reference paper by Onji et al. [60].